Partnership Strategy Mirada's history of integrations with TeraRecon and RamSoft, plus a licensing deal with RefleXion, shows a clear preference for partner led deployments, creating ready made channels to place MiradaXD and AI imaging across hospital networks.

Global Expansion The company already collaborates with leading imaging and technology partners to reach more sites worldwide, signaling a channel focused path to enter new geographies and hospital systems without large direct sales footprints.

Oncology ROI Mirada's software accelerates cancer care by streamlining image registration, contouring and AI autocontouring, enabling faster treatment planning for radiation oncology teams and improving patient throughput, a strong value proposition for cancer centers.

AI Platform A proven AI driven product cadence backed by awards and updates, including workflow enhancements and AI powered contouring, supports a compelling case for enterprise licensing and ongoing service revenue.

Trusted Growth With NHS AI in Health and Care Awards recognition and a global reference base, along with a lean team, Mirada can attract larger integrators and health networks seeking GDPR compliant imaging software that easily integrates with existing systems and scales across regions.